In the past one week, the stock of the pharmaceutical company has rallied 14 per cent as compared to 0.16 per cent decline in ...
Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...
While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...